- March 07, 2025
Announcing the Carol and Gene 2025 Pilot Grant Program Awardees
- July 25, 2024Source: Everyday Health
Can Anxiety Raise Your Dementia Risk? New Study Finds a Link
- June 13, 2024Source: MedPage Today
APOE Genotypes and Dementia
- May 31, 2024
Yale School of Medicine Receives Gift to Support Research on Alzheimer’s Disease and Other Neurodegenerative Disorders
- March 04, 2024Source: The Washington Post
This common precursor to dementia often gets diagnosed late. Experts say that needs to change.
- January 14, 2022
Analyzing the aging brain offers hope for dementia
Carol and Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia
The Carol & Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia operates as a central home at Yale for the study of neurology, neuroscience, and immunobiology interactions as they relate to the dementias and specifically Alzheimer's. Alzheimer’s is currently ranked as the seventh leading cause of death in the United States and is the most common cause of dementia among older adults.
About the Ludwig Program
The Carol & Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia will transform the field of neuroinflammation with the goal of identifying new pathways and interactions, facilitating fundamental discoveries across many platforms, and providing new nodes for therapeutic intervention.
Get Involved
Today, there are more than 55 million people worldwide living with dementia, seven million of whom are in the U.S. As of 2020, Alzheimer’s disease accounted for 60% of cases. There are currently no cures for Alzheimer’s or related disorders, and the urgency to develop effective treatments only grows. It is estimated that by 2050, Alzheimer’s will affect nearly 14 million people in the U.S. alone.
Ludwig Program Seminar Series
The Ludwig Program Seminar Series focuses on the topics of neuroimmunity, neuroinflammation, inflammation, dementia, and Alzheimer's disease, and is led by Yale and national leaders in these topics.